micronized titanium dioxide factory
4. Paper Lithopone is also used in the paper industry as a coating pigment, providing excellent brightness, opacity, and printability.

Another advantage of TIO2 is its excellent stability and resistance to fading. Unlike some other pigments, TIO2 does not degrade or change color over time, ensuring that your products maintain their quality and appearance for longer periods. This makes it an ideal choice for products that are exposed to sunlight or harsh environmental conditions.
Titanium dioxide A1 adopts good oxidation process, composite inorganic coating and organic treatment, and has the characteristics of excellent particle size distribution, high brightness and high weather resistance. It is recommended for high gloss and high weather resistance coatings, inks and outdoor polymer materials.
As a critical component in these diverse applications, the supply chain of micro TiO2 is vital
39
On November 23, 2022, the General Court of the European Union reversed the conclusion that titanium dioxide was carcinogenic and released a statement (1,2):
“First, the Commission made a manifest error in its assessment of the reliability and acceptability of the study on which the classification was based and, second, it infringed the criterion according to which that classification can relate only to a substance that has the intrinsic property to cause cancer.”
As part of our mission at CRIS we base our safety assessments on the currently available scientific evidence and consider many variables (e.g., study quality, journal of publication, etc.), even if it goes against previous conclusions. Evidence-informed decisions making is critical to ensure that the laws and regulations put into place are for the benefit of the population.
The EU General Court maintains that the scientific evidence presented wasn’t the complete picture for the ingredient, “in the present case, the requirement to base the classification of a carcinogenic substance on reliable and acceptable studies was not satisfied.”
“First, the Commission made a manifest error in its assessment of the reliability and acceptability of the study on which the classification was based and, second, it infringed the criterion according to which that classification can relate only to a substance that has the intrinsic property to cause cancer.”
As part of our mission at CRIS we base our safety assessments on the currently available scientific evidence and consider many variables (e.g., study quality, journal of publication, etc.), even if it goes against previous conclusions. Evidence-informed decisions making is critical to ensure that the laws and regulations put into place are for the benefit of the population.
The EU General Court maintains that the scientific evidence presented wasn’t the complete picture for the ingredient, “in the present case, the requirement to base the classification of a carcinogenic substance on reliable and acceptable studies was not satisfied.”